# Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women

> **NCT01833663** · PHASE4 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Overactive Bladder
- Postmenopausal Disorder
- Urination Disorders

## Interventions

- **DRUG:** Solifenacin Succinate Tablets
- **DRUG:** Estrogen

## Key facts

- **NCT ID:** NCT01833663
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2014-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01833663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01833663, "Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT01833663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*